Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Tung NM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Genetic Counseling; Dec2007, Vol. 16 Issue 6, p755-762, 8p
Autor:
Herold CI, Gaughan EM, Lamb CC, Tung NM, Herold, Christina I, Gaughan, Elizabeth M, Lamb, Carolyn C, Tung, Nadine M
Publikováno v:
Clinical Breast Cancer; Dec2011, Vol. 11 Issue 6, p406-408, 3p
Autor:
Domchek SM, Mitchell G, Lindeman GJ, Tung NM, Balmaña J, Isakoff SJ, Schmutzler R, Audeh MW, Loman N, Scott C, Friedlander M, Kaufman B, Garber JE, Tutt A, Robson ME
Publikováno v:
Journal of Clinical Oncology; 11/10/2011, Vol. 29 Issue 32, p4224-4226, 3p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lenz L; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Neff C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Solimeno C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Cogan ES; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Abramson VG; Vanderbilt University Medical Center, Nashville, TN, USA., Boughey JC; Mayo Clinic, Rochester, MN, USA., Falkson C; University of Rochester Medical Center, Rochester, NY, USA., Goetz MP; Mayo Clinic, Rochester, MN, USA., Ford JM; Stanford University School of Medicine, Stanford, CA, USA., Gradishar WJ; Northwestern University, Chicago, IL, USA., Jankowitz RC; University of Pennsylvania, Philadelphia, PA, USA., Kaklamani VG; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Marcom PK; Duke University, Durham, NC, USA., Richardson AL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Storniolo AM; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA., Tung NM; Beth Israel Deaconess Medical Center, Boston, MA, USA., Vinayak S; University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, 15. AstraZeneca, Seattle, WA, USA., Hodgson DR; AstraZeneca, Cambridge, UK., Lai Z; AstraZeneca, Boston, MA, USA., Dearden S; AstraZeneca, Cambridge, UK., Hennessy BT; Royal College of Surgeons in Ireland, Dublin, Ireland., Mayer EL; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mills GB; Oregon Health & Science University, Portland, OR, USA., Slavin TP; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Gutin A; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Connolly RM; Cancer Research @UCC, University College Cork, Cork, Ireland., Telli ML; Stanford University School of Medicine, Stanford, CA, USA., Stearns V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Lanchbury JS; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Timms KM; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA. ktimms@myriad.com.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Nov; Vol. 202 (1), pp. 191-201. Date of Electronic Publication: 2023 Aug 17.
Autor:
Villacampa G; SOLTI Breast Cancer Research Group, Barcelona; Oncology Data Science, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Tung NM; Beth Israel, Boston, USA., Pernas S; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona., Paré L; Reveal Genomics, Barcelona., Bueno-Muiño C; Medical Oncology Department, Hospital Infanta Cristina (Parla), Fundación de Investigación Biomédica del H.U. Puerta de Hierro, Majadahonda, Madrid., Echavarría I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid., López-Tarruella S; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid., Roche-Molina M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid., Del Monte-Millán M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid., Marín-Aguilera M; Reveal Genomics, Barcelona., Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston, USA., Pascual T; SOLTI Breast Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Martínez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Vivancos A; Cancer Genomics Group, VHIO, Barcelona, Spain., Conte PF; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy., Vittoria Dieci M; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy., Griguolo G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy., Cortés J; International Breast Cancer Center, Pangaea Oncology, Quirónsalud Group, Barcelona., Llombart-Cussac A; Arnau de Vilanova Hospital, Universidad Católica de Valencia, Valencia, Spain., Muñoz M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Vidal M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Adamo B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Wolff AC; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore., DeMichele A; Department of Oncology, University of Pennsylvania, Philadelphia., Villagrasa P; Reveal Genomics, Barcelona., Parker JS; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill., Perou CM; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill., Fernandez-Martinez A; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill., Carey LA; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill., Mittendorf EA; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston, USA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, USA., Martín M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid., Prat A; Reveal Genomics, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain; Institute of Oncology (IOB)-Quirón, Barcelona, Spain. Electronic address: alprat@clinic.cat., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Institute of Oncology (IOB)-Quirón, Barcelona, Spain. Electronic address: sara_tolaney@dfci.harvard.edu.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Sep; Vol. 34 (9), pp. 783-795. Date of Electronic Publication: 2023 Jun 09.
Autor:
Batalini F; Mayo Clinic, Phoenix, AZ., Madison RW; Foundation Medicine, Inc, Boston, MA., Sokol ES; Foundation Medicine, Inc, Boston, MA., Jin DX; Foundation Medicine, Inc, Boston, MA., Chen KT; Foundation Medicine, Inc, Boston, MA., Decker B; Foundation Medicine, Inc, Boston, MA., Pavlick DC; Foundation Medicine, Inc, Boston, MA., Frampton GM; Foundation Medicine, Inc, Boston, MA., Wulf GM; Beth Israel Deaconess Medical Center, Boston, MA., Garber JE; Dana Farber Cancer Institute, Boston, MA., Oxnard G; Foundation Medicine, Inc, Boston, MA., Schrock AB; Foundation Medicine, Inc, Boston, MA., Tung NM; Beth Israel Deaconess Medical Center, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2023 Sep; Vol. 7, pp. e2300091.